本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sagimet Biosciences Inc.

10.88
-0.1800-1.63%
盤後10.880.00000.00%19:30 EDT
成交量:63.94萬
成交額:698.32萬
市值:6.76億
市盈率:-8.71
高:11.35
開:11.33
低:10.77
收:11.06
52周最高:11.45
52周最低:4.50
股本:6,215.87萬
流通股本:5,578.08萬
量比:0.59
換手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-1.2490
每股收益(LYR):-1.5800
淨資產收益率:-24.37%
總資產收益率:-16.41%
市淨率:2.64
市盈率(LYR):-6.89

資料載入中...

2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/24

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/23

SEC問詢函

Form CORRESP - Correspondence
2024/01/23

SEC問詢函

Form CORRESP - Correspondence
2024/01/22

重要事件披露

Form 8-K - Current report